168 related articles for article (PubMed ID: 1976501)
21. Decision making in the routine management of myocardial infarction.
Deshmukh H; Weil MH; Rackow EC
Acute Care; 1986; 12(2):95-107. PubMed ID: 2899371
[No Abstract] [Full Text] [Related]
22. [Long-term drug prevention of cardiovascular diseases (methodological aspects)].
Metelitsa VI
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(2):103-7. PubMed ID: 6139116
[No Abstract] [Full Text] [Related]
23. [Secondary prevention following myocardial infarct. Platelet aggregation inhibitors, beta receptor blockers, antiarrhythmics].
Schröder R
Dtsch Med Wochenschr; 1981 Apr; 106(17):546-53. PubMed ID: 6111439
[No Abstract] [Full Text] [Related]
24. Treatment of Acute MI. Institute for Clinical Systems Improvement.
Postgrad Med; 1999 Nov; 106(6):57-8, 62-4, 74-6; passim. PubMed ID: 10576003
[No Abstract] [Full Text] [Related]
25. [Secondary prevention after myocardial infarction].
Preobrazhenskiĭ DV
Kardiologiia; 1993; 33(4):72-9. PubMed ID: 7933799
[No Abstract] [Full Text] [Related]
26. Secondary prevention in acute myocardial infarction.
Mehta RH; Eagle KA
BMJ; 1998 Mar; 316(7134):838-42. PubMed ID: 9549457
[No Abstract] [Full Text] [Related]
27. Medical prophylaxis for the post myocardial infarct patient.
Cohen LS
Cardiol Clin; 1988 Feb; 6(1):173-8. PubMed ID: 2901909
[TBL] [Abstract][Full Text] [Related]
28. [Secondary prevention in the post-infarction period].
Corea L; Bentivoglio M
Cardiologia; 1989 Feb; 34(2):127-33. PubMed ID: 2567624
[No Abstract] [Full Text] [Related]
29. Cardiac death prevention in post-myocardial infarction patients: a review.
Boissel JP; Leizorovicz A; Faucomprez C
Acta Cardiol Suppl; 1980; (25):147-79. PubMed ID: 6103625
[No Abstract] [Full Text] [Related]
30. Role of conventional management and alternative therapies in limiting infarct size in acute myocardial infarction.
Misinski M
Heart Lung; 1987 Nov; 16(6 Pt 2):746-55. PubMed ID: 2890604
[No Abstract] [Full Text] [Related]
31. Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated, controlled trials.
Yusuf S; Lessem J; Jha P; Lonn E
J Hypertens Suppl; 1993 Jun; 11(4):S61-73. PubMed ID: 8104243
[TBL] [Abstract][Full Text] [Related]
32. [Problems in the treatment of patients with ischemic heart disease].
Chazov EI
Ter Arkh; 2000; 72(9):5-9. PubMed ID: 11076406
[No Abstract] [Full Text] [Related]
33. [Treatments of ischemic cardiopathies (IC) and modalities of prescription of aspirin in the three French MONICA centers in 1990].
Cambou JP; Amouyel P; Arveiler D; Bingham A; Ruidavets JB; Montayé M; Haas B; Ferrières J; Lablache Combier B; Richard JL
Ann Cardiol Angeiol (Paris); 1995 Dec; 44(10):578-86. PubMed ID: 8787334
[TBL] [Abstract][Full Text] [Related]
34. [Secondary prevention of acute coronary syndrome].
Motomiya T
J Cardiol; 1999 Mar; 33 Suppl 1():39-43. PubMed ID: 10342135
[TBL] [Abstract][Full Text] [Related]
35. Management of the older person after MI.
Aronow WS
Compr Ther; 1997 Apr; 23(4):259-68. PubMed ID: 9167918
[No Abstract] [Full Text] [Related]
36. [Prevention of myocardial infarction by chemotherapy].
Toshima H; Adachi K
Nihon Rinsho; 1982; 40(11):2465-70. PubMed ID: 6130172
[No Abstract] [Full Text] [Related]
37. Management of postmyocardial infarction in the elderly patient.
Forman R; Aronow WS
Clin Geriatr Med; 1996 Feb; 12(1):169-80. PubMed ID: 8653656
[TBL] [Abstract][Full Text] [Related]
38. [Secondary prevention with drugs].
Burkart F
Schweiz Rundsch Med Prax; 1986 Jan; 75(4):57-60. PubMed ID: 2869563
[No Abstract] [Full Text] [Related]
39. Antihypertensive therapy and myocardial infarction: focus on calcium antagonists.
Bühler FR; Müller FB; Linder L; Bolli P
J Hypertens Suppl; 1985 Nov; 3(2):S95-8. PubMed ID: 2868083
[TBL] [Abstract][Full Text] [Related]
40. Myocardial infarction--secondary prevention.
Hjalmarson A
Acta Med Scand Suppl; 1986; 712():35-9. PubMed ID: 2880462
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
